ATE424385T1

1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 18 April 2022, 4.4 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

103 members in 26 offices

This recordMember, by publication datePriority claim16 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
28466601United States of AmericaP
28466701United States of AmericaP
28466801United States of AmericaP
28466901United States of AmericaP

Members103

Family members, oldest first
DocumentOfficeKind
CA2444198A1CanadaA1
WO02085357A1World Intellectual Property Organization (WIPO)A1
US2003069249A1United States of AmericaA1
NO20034661D0NorwayD0
NO20034661LNorwayL
KR20030096328ARepublic of KoreaA
EP1379246A1European Patent Office (EPO)A1
CZ20032850A3CzechiaA3
MXPA03009600AMexicoA
IL158484A0IsraelA0
HU0401109A2HungaryA2
HUP0401109A2HungaryA2
HK1063149AHong Kong, ChinaA
HK1063149A1Hong Kong, ChinaA1
ZA200308102BSouth AfricaB
CN1561211AChinaA
PL367310A1PolandA1
US6867222B2United States of AmericaB2
RU2003133452ARussian FederationA
JP2005518330AJapanA
US2005159452A1United States of AmericaA1
AU2002307416B2AustraliaB2
EP1379246A4European Patent Office (EPO)A4
NZ528977ANew ZealandA
EP1598338A1European Patent Office (EPO)A1
EP1598339A1European Patent Office (EPO)A1
EP1598340A1European Patent Office (EPO)A1
RU2265018C2Russian FederationC2
BR0209129ABrazilA
HK1086000AHong Kong, ChinaA
HK1086000A1Hong Kong, ChinaA1
HK1088891AHong Kong, ChinaA
HK1088891A1Hong Kong, ChinaA1
HK1088892AHong Kong, ChinaA
HK1088892A1Hong Kong, ChinaA1
KR20060127421ARepublic of KoreaA
RU2005119885ARussian FederationA
NZ540234ANew ZealandA
NZ540235ANew ZealandA
UA77958C2UkraineC2
NZ540233ANew ZealandA
CN100352816CChinaC
HU0401109A3HungaryA3
HUP0401109A3HungaryA3
NZ551453ANew ZealandA
EP1918279A2European Patent Office (EPO)A2
EP1930322A1European Patent Office (EPO)A1
EP1918279A3European Patent Office (EPO)A3
KR100847296B1Republic of KoreaB1
EP1379246B1European Patent Office (EPO)B1
AT410165TAustriaT
ATE410165T1AustriaT1
DE60229224D1GermanyD1
KR100878774B1Republic of KoreaB1
PT1379246EPortugalE
DK1379246T3DenmarkT3
EP1598338B1European Patent Office (EPO)B1
US7495109B2United States of AmericaB2
EP1598340B1European Patent Office (EPO)B1
AT423098TAustriaT
AT424385TAustriaT
ATE423098T1AustriaT1
ATE424385T1This recordAustriaT1
ES2315394T3SpainT3
DE60231257D1GermanyD1
PT1598340EPortugalE
DE60231442D1GermanyD1
EP2050450A1European Patent Office (EPO)A1
SI1379246T1SloveniaT1
PT1598338EPortugalE
DK1598340T3DenmarkT3
DK1598338T3DenmarkT3
ES2322158T3SpainT3
US2009156640A1United States of AmericaA1
EP1598339B1European Patent Office (EPO)B1
SI1598338T1SloveniaT1
AT434607TAustriaT
ATE434607T1AustriaT1
ES2323876T3SpainT3
DE60232752D1GermanyD1
SI1598340T1SloveniaT1
PT1598339EPortugalE
DK1598339T3DenmarkT3
JP2009263378AJapanA
JP2009263379AJapanA
JP2009263380AJapanA
EP1598338B9European Patent Office (EPO)B9
JP4364513B2JapanB2
ES2329252T3SpainT3
SI1598339T1SloveniaT1
DK1598338T5DenmarkT5
CA2444198CCanadaC
IL158484AIsraelA
IL208903A0IsraelA0
IL208907A0IsraelA0
US7939670B2United States of AmericaB2
RU2426730C2Russian FederationC2
US2012095049A1United States of AmericaA1
IL208903AIsraelA
US8252815B2United States of AmericaB2
Showing 100 of 103